HIV pharmaccines

Details for Australian Patent Application No. 2004276559 (hide)

Owner Oxxon Therapeutics Limited

Inventors Schneider, Joerg

Agent Fisher Adams Kelly

Pub. Number AU-A-2004276559

PCT Pub. Number WO2005/030964

Priority 0322637.0 26.09.03 GB; 0322402.9 24.09.03 GB; 0325011.5 27.10.03 GB

Filing date 23 September 2004

Wipo publication date 7 April 2005

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C12N 15/49 (2006.01) Mutation or genetic engineering

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030964 Priority application(s): WO2005/030964

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004276562-Optical imaging system with optical delay lines

2004276541-Method of producing self-supporting substrates comprising III-nitrides by means of heteroepitaxy on a sacrificial layer